347
Views
16
CrossRef citations to date
0
Altmetric
Research Article

Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resistant tuberculosis

, , &
Pages 1321-1331 | Received 03 Jan 2019, Accepted 15 Apr 2019, Published online: 21 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Sara Bahrainian, Mohammadreza Rouini & Kambiz Gilani. (2021) Preparation and evaluation of vancomycin spray-dried powders for pulmonary delivery. Pharmaceutical Development and Technology 26:6, pages 647-660.
Read now

Articles from other publishers (14)

Shadi Yaqoubi, Mohaddese Sokuti, Sahand Mazloum-Ravasan, Kofi Asare-Addo, Hamed Hamishehkar & Ali Nokhodchi. (2024) Preparing dry powder inhalation formulation of salbutamol sulfate using an ultrasonic atomizer device. Journal of Aerosol Science 175, pages 106290.
Crossref
Tushar Saha, Shubhra Sinha, Rhodri Harfoot, Miguel E. Quiñones-Mateu & Shyamal C. Das. (2023) Inhalable dry powder containing remdesivir and disulfiram: Preparation and in vitro characterization. International Journal of Pharmaceutics, pages 123411.
Crossref
Prakash Khadka, Jack Dummer, Philip C. Hill, Rajesh Katare & Shyamal C. Das. (2022) A review of formulations and preclinical studies of inhaled rifampicin for its clinical translation. Drug Delivery and Translational Research 13:5, pages 1246-1271.
Crossref
Zitong Shao, Michael Y. T. Chow, Shing Fung Chow & Jenny K. W. Lam. (2023) Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis. Pharmaceutical Research 40:5, pages 1073-1086.
Crossref
Sachin S. Gaikwad, Snehal R. Pathare, Mayur A. More, Nikita A. Waykhinde, Umesh D. Laddha, Kishor S. Salunkhe, Sanjay J. Kshirsagar, Sakshi S. Patil & Kuldeep H. Ramteke. (2023) Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies. Journal of Controlled Release 355, pages 292-311.
Crossref
Riya Mahar, Arpita Chakraborty & Nidhi Nainwal. (2022) The influence of carrier type, physical characteristics, and blending techniques on the performance of dry powder inhalers. Journal of Drug Delivery Science and Technology 76, pages 103759.
Crossref
Nidhi Nainwal, Yuwanshi Sharma & Vikash Jakhmola. (2022) Dry powder inhalers of antitubercular drugs. Tuberculosis 135, pages 102228.
Crossref
Xiang Wang, Zuozhou Xie, Jinhong Zhao, Zhenghua Zhu, Chen Yang & Yi Liu. (2021) Prospects of Inhaled Phage Therapy for Combatting Pulmonary Infections. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Daan Zillen, Max Beugeling, Wouter L.J. Hinrichs, Henderik W. Frijlink & Floris Grasmeijer. (2021) Natural and bioinspired excipients for dry powder inhalation formulations. Current Opinion in Colloid & Interface Science 56, pages 101497.
Crossref
Nasser Alhajj, Niall J. O'Reilly & Helen Cathcart. (2021) Leucine as an excipient in spray dried powder for inhalation. Drug Discovery Today 26:10, pages 2384-2396.
Crossref
Hisham Al-Obaidi, Amy Granger, Thomas Hibbard & Sefinat Opesanwo. (2021) Pulmonary Drug Delivery of Antimicrobials and Anticancer Drugs Using Solid Dispersions. Pharmaceutics 13:7, pages 1056.
Crossref
Shadi Yaqoubi, Hak-Kim Chan, Ali Nokhodchi, Siavoush Dastmalchi, Ali Akbar Alizadeh, Mohammad Barzegar-Jalali, Khosro Adibkia & Hamed Hamishehkar. (2021) A quantitative approach to predicting lung deposition profiles of pharmaceutical powder aerosols. International Journal of Pharmaceutics 602, pages 120568.
Crossref
Mohammad A. M. Momin, Bhamini Rangnekar, Shubhra Sinha, Chen-Yi Cheung, Gregory M. Cook & Shyamal C. Das. (2019) Inhalable Dry Powder of Bedaquiline for Pulmonary Tuberculosis: In Vitro Physicochemical Characterization, Antimicrobial Activity and Safety Studies. Pharmaceutics 11:10, pages 502.
Crossref
Bhamini Rangnekar, Mohammad A.M. Momin, Basanth Babu Eedara, Shubhra Sinha & Shyamal C. Das. (2019) Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis. International Journal of Pharmaceutics 570, pages 118689.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.